216 related articles for article (PubMed ID: 37072468)
41. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis.
Tanaka M; Riddell RH; Saito H; Soma Y; Hidaka H; Kudo H
Scand J Gastroenterol; 1999 Jan; 34(1):55-67. PubMed ID: 10048734
[TBL] [Abstract][Full Text] [Related]
42. Subclinical bowel inflammation increases healthcare resources utilization and steroid use before diagnosis of inflammatory bowel disease.
Rodríguez-Lago I; Aguirre U; Ramírez de la Piscina P; Muñagorri A; Zapata E; Higuera R; Montalvo I; Iriarte A; Fernández-Calderón M; Arreba P; Carrascosa J; Cabriada JL; Barreiro-de Acosta M
United European Gastroenterol J; 2023 Feb; 11(1):9-18. PubMed ID: 36547009
[TBL] [Abstract][Full Text] [Related]
43. Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer.
Lavelle A; Nancey S; Reimund JM; Laharie D; Marteau P; Treton X; Allez M; Roblin X; Malamut G; Oeuvray C; Rolhion N; Dray X; Rainteau D; Lamaziere A; Gauliard E; Kirchgesner J; Beaugerie L; Seksik P; Peyrin-Biroulet L; Sokol H
Gut Microbes; 2022; 14(1):2078620. PubMed ID: 35638103
[TBL] [Abstract][Full Text] [Related]
44. Performance of the Montreal classification for inflammatory bowel diseases.
Spekhorst LM; Visschedijk MC; Alberts R; Festen EA; van der Wouden EJ; Dijkstra G; Weersma RK;
World J Gastroenterol; 2014 Nov; 20(41):15374-81. PubMed ID: 25386087
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of serum neutrophil gelatinase-associated lipocalin (NGAL), asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) levels, and their relations with disease type and activity in inflammatory bowel diseases.
Korkmaz H; Asıl M; Temel T; Öztürk B; Kebapçılar L
Turk J Med Sci; 2021 Oct; 51(5):2403-2412. PubMed ID: 33984894
[TBL] [Abstract][Full Text] [Related]
46. Fecal transplantation for treatment of inflammatory bowel disease.
Imdad A; Nicholson MR; Tanner-Smith EE; Zackular JP; Gomez-Duarte OG; Beaulieu DB; Acra S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012774. PubMed ID: 30480772
[TBL] [Abstract][Full Text] [Related]
47. Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients.
Juliao-Baños F; Kock J; Arrubla M; Calixto O; Camargo J; Cruz L; Hurtado J; Clavijo A; Donado J; Schwartz S; Abreu MT; Damas OM
Medicine (Baltimore); 2021 Feb; 100(7):e24729. PubMed ID: 33607817
[TBL] [Abstract][Full Text] [Related]
48. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
49. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study).
Henriksen M; Jahnsen J; Lygren I; Sauar J; Schulz T; Stray N; Vatn MH; Moum B;
Scand J Gastroenterol; 2006 Sep; 41(9):1037-43. PubMed ID: 16938716
[TBL] [Abstract][Full Text] [Related]
50. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
Yang Z; Clark N; Park KT
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):253-62.e2. PubMed ID: 23883663
[TBL] [Abstract][Full Text] [Related]
51. Diagnostics of inflammatory bowel disease.
Nikolaus S; Schreiber S
Gastroenterology; 2007 Nov; 133(5):1670-89. PubMed ID: 17983810
[TBL] [Abstract][Full Text] [Related]
52. Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' Consortium.
Banerjee R; Pal P; Hilmi I; Ghoshal UC; Desai DC; Rahman MM; Dutta U; Mohiuddin SA; Al Mohannadi M; Philip M; Ramesh GN; Niriella MA; De Silva AP; de Silva HJ; Pisespongsa P; Limsrivilai J; Aniwan S; Nawarathne M; Fernandopulle N; Aye TT; Ni N; Al Awadhi S; Joshi N; Ngoc PTV; Kieu TV; Nguyen AD; Abdullah M; Ali E; Zeid A; Sollano JD; Saberi B; Omar M; Mohsin MN; Aftab H; Wai TM; Shastri YM; Chaudhuri S; Ahmed F; Bhatia SJ; Travis SPL;
J Gastroenterol Hepatol; 2022 Jun; 37(6):1004-1015. PubMed ID: 35178742
[TBL] [Abstract][Full Text] [Related]
53. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
[TBL] [Abstract][Full Text] [Related]
54. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
[TBL] [Abstract][Full Text] [Related]
55. Paediatric Inflammatory Bowel Disease and its Relationship with the Microbiome.
Fitzgerald RS; Sanderson IR; Claesson MJ
Microb Ecol; 2021 Nov; 82(4):833-844. PubMed ID: 33666710
[TBL] [Abstract][Full Text] [Related]
56. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.
Nishino K; Nishida A; Inoue R; Kawada Y; Ohno M; Sakai S; Inatomi O; Bamba S; Sugimoto M; Kawahara M; Naito Y; Andoh A
J Gastroenterol; 2018 Jan; 53(1):95-106. PubMed ID: 28852861
[TBL] [Abstract][Full Text] [Related]
57. Location-specific signatures of Crohn's disease at a multi-omics scale.
Gonzalez CG; Mills RH; Zhu Q; Sauceda C; Knight R; Dulai PS; Gonzalez DJ
Microbiome; 2022 Aug; 10(1):133. PubMed ID: 35999575
[TBL] [Abstract][Full Text] [Related]
58. Presenting symptoms in inflammatory bowel disease: descriptive analysis of a community-based inception cohort.
Perler BK; Ungaro R; Baird G; Mallette M; Bright R; Shah S; Shapiro J; Sands BE
BMC Gastroenterol; 2019 Apr; 19(1):47. PubMed ID: 30940072
[TBL] [Abstract][Full Text] [Related]
59. Inflammatory bowel disease.
Casey G
Nurs N Z; 2017 Mar; 23(2):20-24. PubMed ID: 30556986
[TBL] [Abstract][Full Text] [Related]
60. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]